Ciclomex-20 consists of Gestodene, ethinylestradiol.
Gestodene - Not Available
Oral As part of combined oral contraceptive
Adult: 75 mcg daily in monophasic preparations, 50-100 mcg daily in triphasic preparations. Oral Menopausal hormone replacement therapy
Adult: 25 or 50 mcg daily for 12 days of a 28-day cycle.
Adult: PO As part of combined oral contraceptive 75 mcg/day in monophasic preparations; 50-100 mcg/day in triphasic preparations. Menopausal HRT 25 or 50 mcg/day for 12 days of a 28-day cycle.
ethinylestradiol - Oral Menopausal hormone replacement therapy
Adult: In menopausal women: 10-20 mcg daily in conjunction with a progestogen in women with uterus. Oral Female hypogonadism
Adult: 10-50 mcg daily in a cyclical regimen. Oral Palliative treatment of breast carcinoma
Adult: In postmenopausal women: 0.1-1 mg tid. Oral Palliative treatment of prostatic carcinoma
Adult: 0.15-3 mg daily. Oral As part of combined oral contraceptive
Adult: As the oestrogenic component of combined oral contraceptive: 20-40 mcg/day.
Adult: PO Menopausal HRT 10-20 mcg/day w/ progestogen in women w/ uterus. Female hypogonadism 10-50 mcg/day in a cyclical regimen. Palliation of malignant breast neoplasms in postmenopausal women 0.1-1 mg 3 times/day. Palliation of prostatic carcinoma 0.15-3 mg/day. Combined OC As the oestrogenic component: 20-40 mcg/day.